Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
UnitedHealth Group (UHG) has been overcharging some cancer patients by more than 1,000 percent for live-changing drugs, a ...
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its ...
SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its ...
Invesco S&P 500 Pure Value ETF offers low valuations, but underperforms peers due to high volatility and expenses. Read what ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
The report is the latest indictment of America’s broken healthcare system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback